Dr. Larry Norton

Dr. Larry Norton, MD, is a pioneering medical oncologist whose visionary leadership and scientific innovation have profoundly influenced the field of breast cancer treatment. He serves as the Medical Director of the Evelyn H. Lauder Breast Center at Memorial Sloan Kettering Cancer Center and holds the Norna S. Sarofim Chair in Clinical Oncology. A graduate of Columbia University Vagelos College of Physicians and Surgeons, Dr. Norton completed his residency in internal medicine at Beth Israel Hospital and a fellowship in medical oncology at the National Cancer Institute. Board-certified in Internal Medicine and Medical Oncology, he is internationally known for advancing cancer treatment through both clinical excellence and groundbreaking research.

Dr. Norton is the architect of the Norton-Simon Hypothesis, a foundational model of tumor growth and chemotherapy response that has transformed how oncologists understand cancer dynamics. His work laid the scientific groundwork for dose-dense chemotherapy, a strategy now widely adopted for its survival benefit in breast cancer. He has led numerous clinical trials and published extensively in top-tier journals, contributing to the development of modern treatment paradigms in solid tumor oncology. As a co-founder of the Breast Cancer Research Foundation, he has also been a fierce advocate for funding patient-centered, high-impact research.

In addition to his clinical and research achievements, Dr. Norton is a celebrated educator and mentor, shaping generations of oncologists and researchers. He has served in leadership roles within major organizations, including as President of the American Society of Clinical Oncology and as a member of the National Cancer Policy Board. Dr. Norton has received numerous accolades for his lifelong commitment to cancer care, including election to the Institute of Medicine and multiple lifetime achievement awards. Through his trailblazing work and enduring influence, Dr. Norton continues to redefine excellence in breast cancer treatment and cancer research.